BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15811115)

  • 21. [The nucleolus organizer region in benign and malignant melanocyte lesions of the skin: a quantitative study].
    Sementa AR; Gambini C; Borgiani L; Palladino M; Corso M; Canepa M
    Pathologica; 1989; 81(1073):231-7. PubMed ID: 2484303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER3 expression in cutaneous tumors.
    Wimmer E; Kraehn-Senftleben G; Issing WJ
    Anticancer Res; 2008; 28(2A):973-9. PubMed ID: 18507044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumors composed of malignant epithelial and melanocytic populations: a case series and review of the literature.
    Satter EK; Metcalf J; Lountzis N; Elston DM
    J Cutan Pathol; 2009 Feb; 36(2):211-9. PubMed ID: 18727668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ; Wright AL; Cotton DW; Reeve S
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
    Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
    Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleolar organizer regions in a model of cell hyperactivity and regression.
    Morales A; Schwint AE; Itoiz ME
    Biocell; 1996 Dec; 20(3):251-8. PubMed ID: 9031592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-affinity nerve growth factor receptor (P75 NGFR) as a marker of perineural invasion in malignant melanomas.
    Chan MM; Tahan SR
    J Cutan Pathol; 2010 Mar; 37(3):336-43. PubMed ID: 19615036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common skin cancers.
    Lee PK
    Minn Med; 2004 Mar; 87(3):44-7. PubMed ID: 15080294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT; Orrell JM; Grant A
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues.
    Ofner D; Bankfalvi A; Riehemann K; Bier B; Böcker W; Schmid KW
    Mod Pathol; 1994 Dec; 7(9):946-50. PubMed ID: 7892164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of RUNX3 in skin cancers.
    Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
    Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of silver binding nucleolar organizer regions in exfoliative cytology smears of potentially malignant and malignant oral lesions.
    Sowmya GV; Nahar P; Astekar M; Agarwal H; Singh MP
    Biotech Histochem; 2017; 92(2):115-121. PubMed ID: 28296547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nucleolar organizer regions in uterine cervical cancer and its precursor epithelial lesions].
    Wistuba I; Roa I; Araya JC; Villaseca M; Capurro I; Rojo J
    Rev Med Chil; 1993 Oct; 121(10):1110-7. PubMed ID: 8191113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Histologic and histochemical characteristics of the stroma in relation to the degree of malignancy and type of malignant epithelial tumor and precancerous conditions of the skin].
    Ićurup Z
    Med Pregl; 1988; 41(7-8):282-6. PubMed ID: 3246976
    [No Abstract]   [Full Text] [Related]  

  • 37. Morphometric study of nucleolar organiser regions in ameloblastoma and basal cell carcinoma.
    Rosa LE; Jaeger MM; Jaeger RG
    Oral Oncol; 1997 May; 33(3):209-14. PubMed ID: 9307731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
    Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
    J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AgNOR counts in preneoplastic lesions of the bronchus.
    Fisseler-Eckhoff A; Becker T; Sudhoff H; Müller KM
    Pathol Res Pract; 1994 Apr; 190(4):389-93. PubMed ID: 8078808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.